The following biotech stocks reached a 52-week high on September 16, 2026, driven by positive results from clinical trials or an upcoming conference participation. BlossomHill Therapeutics is a ...

Expanded, pan-ethnic carrier screening is gaining traction, driven by cheaper sequencing, AI interpretation and digital counseling, with opportunities in clinics, fertility care and consumer ...

Forty-four years ago, Nadrian Seeman published his groundbreaking ideas on using DNA as a structural material, expanding ...

A new genome-editing method, prime assembly, precisely inserts long DNA sequences into targeted genomic locations.

Scientists have discovered a powerful gene-targeting system in viruses. Billions of years old, VIPR seems to predate CRISPR ...

Researchers at Maynooth University (MU) have developed a first-of-its-kind DNA computer, described as one of the most complex and fastest molecular computers yet reported.

Genomic editing holds great potential yet continues to have its limitations. Most current methods either rely on untargeted ...

AI, Advanced Sequencing and Precision Medicine Drive Genomics Opportunities Across Diagnostics, Drug Development and Preventive CareDublin, Sept. (GLOBE NEWSWIRE) -- "Genomics Market Opportunity, ...

Danaher companies Integrated DNA Technologies (IDT), a global leader in genomics, and Aldevron, a premier manufacturing partner for DNA, RNA, and protein, today announced the launch of research grade ...

Opportunities center on AI-driven design, high-throughput screening, bioinformatics, RNA therapies, nanotechnology, pharmacogenomics and integrated R&D platforms.Dublin, Sept. 14, 2026 (GLOBE NEWSWIRE ...

Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applica ...